Through systematic examination of LEF’s immunomodulatory properties on melanocyte-specific CD8+ T lymphocytes and associated inflammatory cytokine networks, we aimed to elucidate both the therapeutic potential and underlying molecular mechanisms of LEF as a novel treatment candidate for vitiligo. This evidence concerns the gene CD8A and vitiligo.